French ad firm Publicis and Hikma settle US opioid lawsuits for $500m
Publicis Health has agreed to pay $350m to settle allegations made by all states and territories in the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Feb 24
Publicis Health has agreed to pay $350m to settle allegations made by all states and territories in the…
02 Feb 24
According to the long-term data, around 60% of people getting Vabysmo in BALATON and up to 48% of…
01 Feb 24
Rusfertide is an investigational injectable hepcidin mimetic peptide of the natural hormone hepcidin, which is currently in the…
31 Jan 24
In both randomised controlled trials for abdominoplasty and bunionectomy, treatment with VX-548 resulted in a statistically significant improvement…
31 Jan 24
Under the agreement, Regeneron will buy full development and commercialisation rights of 2seventy’s pipeline of investigational immune cell…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
31 Jan 24
The funds will be used to advance the development of Cour’s Myasthenia Gravis and Type 1 Diabetes product…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
31 Jan 24
QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, today announced their enhanced QIAGEN CLC Genomics Workbench Premium…
31 Jan 24
This platformization of new technologies will enable our clients to accelerate the discovery of preclinical ADC candidates (PCCs)…
31 Jan 24
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment…
30 Jan 24
Gilead has also made a $320m equity investment in Arcus and appointed its chief commercial officer Johanna Mercier…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates